script src="//load.sumome.com/" data-sumo-site-id="aa6c3d60b32e5862815eb98663e1413c4f7864fbc2afb58dd5f1de51d4a7cfe4/script Talkpropeller's Articles: Cystic fibrosis drug halts lung damage in young children

Art for art sake

Art for art sake

Friday, June 9, 2017

Cystic fibrosis drug halts lung damage in young children

Orkambi targets the most common mutation for cystic fibrosis, but is not available in the UK on the NHS. Now a trial has shown promising effects in children

via New Scientist - Health Read More Here..